Kaspar von Meyenburg
Plus aucun poste en cours
Profil
Kaspar von Meyenburg served as the Director-Executive Board at ImVisioN Therapeutics AG.
Prior to that, he was the Head of Biotechnology & Pharma research at Ciba Holding AG.
He also worked as a Professor at the Technical University of Denmark and the University of Copenhagen.
Dr. von Meyenburg holds a doctorate degree from the Swiss Federal Institute of Technology.
Anciens postes connus de Kaspar von Meyenburg
| Sociétés | Poste | Fin |
|---|---|---|
ImVisioN Therapeutics AG
 ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services ImVisioN Therapeutics AG is a Swiss, clinical stage immunotherapy company developing novel treatments to cure allergies. The Company is the pioneer in intralymphatic immunotherapy (ILIT ™), a proprietary technology for the delivery of immunotherapeutics in the treatment of allergies. ILIT ™ is clinically proven and has been shown to be a safer, more efficacious and more convenient means of delivering allergy therapeutics. By applying another proprietary technology, Modular Antigen Transportation ™ (MAT ™), ImVisioN leverages the potential of ILIT ™ to develop drugs that use allergens safely for specific and highly effective antigen presentation. ImVisioN's lead product is for the treatment of cat dander allergy and the Company has programs addressing birch pollen and house dust mite allergies. The Company's proprietary technology platforms are applicable to further allergy targets, which may be addressed in the future. | Corporate Officer/Principal | 13/02/2014 |
Ciba Holding AG
 Ciba Holding AG Chemicals: Major DiversifiedProcess Industries Ciba Holding AG manufactures and markets chemicals that provide color, performance and care for plastics, coatings, textile, paper, home & personal care and other products. The firm provides services to the plastic, rubber, adhesives lubricant, home and personal care, coatings, graphic arts, electronic, detergents and hygiene industries. It operates through four segments Plastic Additives, Coating Effects, Water & Paper Treatment and Textile Effects. The company has offices in Europe, America and Asia. Ciba Holding was founded on April 24, 1996 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/01/1993 |
| Technical University of Denmark | Corporate Officer/Principal | 01/01/1987 |
| University of Copenhagen | Corporate Officer/Principal | 01/01/1970 |
Formation de Kaspar von Meyenburg
| Swiss Federal Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
ImVisioN Therapeutics AG
ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services ImVisioN Therapeutics AG is a Swiss, clinical stage immunotherapy company developing novel treatments to cure allergies. The Company is the pioneer in intralymphatic immunotherapy (ILIT ™), a proprietary technology for the delivery of immunotherapeutics in the treatment of allergies. ILIT ™ is clinically proven and has been shown to be a safer, more efficacious and more convenient means of delivering allergy therapeutics. By applying another proprietary technology, Modular Antigen Transportation ™ (MAT ™), ImVisioN leverages the potential of ILIT ™ to develop drugs that use allergens safely for specific and highly effective antigen presentation. ImVisioN's lead product is for the treatment of cat dander allergy and the Company has programs addressing birch pollen and house dust mite allergies. The Company's proprietary technology platforms are applicable to further allergy targets, which may be addressed in the future. | Commercial Services |
Ciba Holding AG
Ciba Holding AG Chemicals: Major DiversifiedProcess Industries Ciba Holding AG manufactures and markets chemicals that provide color, performance and care for plastics, coatings, textile, paper, home & personal care and other products. The firm provides services to the plastic, rubber, adhesives lubricant, home and personal care, coatings, graphic arts, electronic, detergents and hygiene industries. It operates through four segments Plastic Additives, Coating Effects, Water & Paper Treatment and Textile Effects. The company has offices in Europe, America and Asia. Ciba Holding was founded on April 24, 1996 and is headquartered in Basel, Switzerland. | Process Industries |